Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by the real-world impact of CRISPR technology. They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.

Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by the real-world impact of CRISPR technology. They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.

Bluebee is a leading provider of high performance genomics solutions, enabling research and clinical labs to substantially reduce cost and time-to-diagnose. Bluebee provides a unique cloud-based accelerated genomics platform to enable fast, efficient and affordable processing of large volumes of genomics data. Genetic analyses are currently undergoing extreme changes as a result of revolutionary developments in next generation DNA sequencing technology. While personalized treatment comes with great promises, routine clinical implementation of whole genome based diagnostics is still faced with major technological and biological challenges: the ever-growing amounts of data generated, the inherent need for faster data processing and deep analytics, and the increasing necessity of flexibility and reliability resulting from the vastness of the application spectrum.

Bluebee is a leading provider of high performance genomics solutions, enabling research and clinical labs to substantially reduce cost and time-to-diagnose. Bluebee provides a unique cloud-based accelerated genomics platform to enable fast, efficient and affordable processing of large volumes of genomics data. Genetic analyses are currently undergoing extreme changes as a result of revolutionary developments in next generation DNA sequencing technology. While personalized treatment comes with great promises, routine clinical implementation of whole genome based diagnostics is still faced with major technological and biological challenges: the ever-growing amounts of data generated, the inherent need for faster data processing and deep analytics, and the increasing necessity of flexibility and reliability resulting from the vastness of the application spectrum.